Nancy Law Impact Award

The Myasthenia Gravis Foundation of America (MGFA) requests submission of proposals to support high-impact clinical research and scientific pilot studies that are focused and innovative. 

The research committee has identified five broad research priorities of unmet need in the field of neuromuscular junction disorders:

• Biomarkers
• Mechanisms of disease
• Therapeutic strategies
• Improving patient outcomes
• Pediatric treatment strategies, safety concerns, and long-term outcomes

Funding: $100,000 per year

Duration: 3 years

Research Authority due date: 6.6.24

LOI (required) due date: 14.7.24

Full proposal due date: 6.9.24